Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

NewGenIvf Group Ltd (NIVF) Form 6-K — Aug 17, 2026

$NIVFForm 6-KFiled Aug 17, 2026, 8:30 AM ET0001213900-26-090519Original filing

NewGenIvf Group Limited issued a new senior convertible note in the aggregate principal amount of $7,105,468.75 to an institutional investor on August 14, 2026, in exchange for the investor's existing convertible notes (originally $5,200,000 in combined principal) and related warrants, under a Section 3(a)(9) private exchange agreement dated August 11, 2026. The exchange effectively restructures a June 2026 repurchase agreement under which the company owed $7,381,250 for its existing securities and still had $6,746,250 outstanding — indicating the company could not satisfy the obligation in cash.

Key figures

Floor price
0.1218
Default rate
18% per annum
Exchange date
2026-08-14
Conversion price
0.5517
Exchange agreement date
2026-08-11
Beneficial ownership cap
9.99%
Alternate conversion price
greater of $0.1218 floor or 76% of trailing 10-day VWAP
Required share reservation
125% of maximum conversion shares at floor price
Cross default threshold usd
150000
Repurchase outstanding balance usd
6746250
Eastern standard note principal usd
850000
Change of control redemption premium
125%
July 2025 note original principal usd
2000000
June 2025 note original principal usd
3200000
Repurchase aggregate payment amount usd
7381250

AI analysis

Red flags6 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    NewGenIvf Group Ltd (NIVF) Form 6-K — Aug 17, 2026: AI Analysis | Signal8